Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! View ALL results for your Stocks, ETFs and Funds Screeners with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Bioatla Inc (BCAB)

Bioatla Inc (BCAB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 33,470
  • Shares Outstanding, K 48,346
  • Annual Sales, $ 0 K
  • Annual Income, $ -123,460 K
  • EBIT $ -86 M
  • EBITDA $ -85 M
  • 60-Month Beta 0.96
  • Price/Sales 3.02
  • Price/Cash Flow N/A
  • Price/Book 2.50
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -1.70
  • Most Recent Earnings $-0.22 on 11/07/24
  • Next Earnings Date N/A
  • Annual Dividend & Yield N/A (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Options Overview Details

View History
  • Implied Volatility 377.49% ( +187.40%)
  • Historical Volatility 176.04%
  • IV Percentile 98%
  • IV Rank 45.98%
  • IV High 760.51% on 06/28/24
  • IV Low 51.43% on 02/12/24
  • Put/Call Vol Ratio 0.41
  • Today's Volume 145
  • Volume Avg (30-Day) 126
  • Put/Call OI Ratio 0.12
  • Today's Open Interest 7,005
  • Open Int (30-Day) 6,558

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 4 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/24
See More
  • Average Estimate -0.34
  • Number of Estimates 2
  • High Estimate -0.33
  • Low Estimate -0.35
  • Prior Year -0.56
  • Growth Rate Est. (year over year) +39.29%

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.6700 +3.33%
on 12/20/24
1.9000 -63.56%
on 11/22/24
-0.7877 (-53.22%)
since 11/20/24
3-Month
0.6700 +3.33%
on 12/20/24
2.5250 -72.58%
on 11/11/24
-1.0277 (-59.75%)
since 09/20/24
52-Week
0.6700 +3.33%
on 12/20/24
4.0200 -82.78%
on 04/04/24
-1.3277 (-65.73%)
since 12/20/23

Most Recent Stories

More News
BioAtla, Inc. Announces Registered Direct Offering to Advance Two Mid-Stage Clinical Programs to Key Inflection Points

BCAB : 0.6923 (-41.82%)
BioAtla Reports Improved Survival Outcomes in NSCLC Patients with Mutated KRAS Treated with Mecbotamab Vedotin

Mec-V shows improved one-year survival in mKRAS NSCLC patients compared to wtKRAS, supporting further clinical trials.Quiver AI SummaryBioAtla, Inc. reported promising results for its treatment, Mecbotamab...

BCAB : 0.6923 (-41.82%)
BioAtla Presented Data Characterizing Mutated KRAS Genotype and Clinical Outcomes in Patients with Advanced NSCLC Treated with Mecbotamab Vedotin (Mec-V), a CAB-AXL-ADC, at the IASLC 2024 Hot Topic in Basic & Translational Science Meeting

BCAB : 0.6923 (-41.82%)
BioAtla, Inc. to Present Research on Mecbotamab Vedotin at IASLC 2024 Meeting

BioAtla will present research on Mecbotamab Vedotin at the IASLC meeting December 14, 2024, in Washington, DC.Quiver AI SummaryBioAtla, Inc., a clinical-stage biotechnology company specializing in Conditionally...

BCAB : 0.6923 (-41.82%)
BioAtla Announces Upcoming Poster Presentation at the IASLC 2024 Hot Topic in Basic & Translational Science Meeting

BCAB : 0.6923 (-41.82%)
Michael Burry Cautiously Ups Alibaba, JD.com, Baidu Bets With Offsetting Hedges: Retail Doesn’t Share Big Short Investor’s Optimism

Burry is known for accurately predicting the 2007 subprime mortgage crisis that later morphed into the global financial crisis.

BABA : 82.28 (-2.41%)
ACIC : 13.13 (+0.92%)
MCHI : 47.10 (+0.81%)
BIDU : 85.80 (+0.26%)
REAL : 9.39 (+6.40%)
HPP : 2.93 (+12.26%)
JD : 35.64 (-0.75%)
BCAB : 0.6923 (-41.82%)
BioAtla Reports Third Quarter 2024 Financial Results and Highlights Recent Progress

BCAB : 0.6923 (-41.82%)
BioAtla to Announce Third Quarter 2024 Financial Results and Provide Business Highlights on November 7, 2024

BCAB : 0.6923 (-41.82%)
BioAtla Announces Upcoming Poster Presentation at the 39th Society for Immunotherapy of Cancer Annual Meeting

BCAB : 0.6923 (-41.82%)
Viatris Announces Appointments of Scott A. Smith and Elisha W. Finney to the Company's Board of Directors

/PRNewswire/ -- Viatris Inc. (NASDAQ: VTRS), a global healthcare company, today announced that Scott A. Smith and Elisha W. Finney have been appointed as...

BCAB : 0.6923 (-41.82%)
VTRS : 12.52 (+3.22%)

Business Summary

BioAtla Inc. is a clinical-stage biopharmaceutical company. It engages in developing a novel class of antibody-based therapeutics for the treatment of solid tumor cancer. BioAtla Inc. is based in SAN DIEGO.

See More

Key Turning Points

3rd Resistance Point 1.3682
2nd Resistance Point 1.2241
1st Resistance Point 0.9582
Last Price 0.6923
1st Support Level 0.5482
2nd Support Level 0.4041
3rd Support Level 0.1382

See More

52-Week High 4.0200
Fibonacci 61.8% 2.7403
Fibonacci 50% 2.3450
Fibonacci 38.2% 1.9497
Last Price 0.6923
52-Week Low 0.6700

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar